← Back to Directory

Aclarion, Inc. (ACON) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Aclarion, Inc. (ACON).

Download StockRank on Google Play Download StockRank on the App Store

Equity Details

Price & Market Data

Price: $3.15

Daily Change: +$0.05 / 1.59%

Daily Range: $3.03 - $3.19

Market Cap: $7,756,087

Daily Volume: 80,822

Performance Metrics

1 Week: -1.56%

1 Month: -1.87%

3 Months: 15.38%

6 Months: -56.43%

1 Year: -58.55%

YTD: -31.52%

About Aclarion, Inc. (ACON)

Explore comprehensive market data for Aclarion, Inc. (ACON). Currently priced at 3.15, observe its daily movement of +$0.05 / 1.59%. The total market value is 7,756,087. Review its performance across various timeframes, including the last week, month, and year, to understand its trajectory.

Company Details

Employees: 11

Sector: Technology services

Industry: Packaged software

Country: United States

Details

Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. It also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs which extends the time of a standard lumbar MRI exam; and imaging data transfer products, including AMBRA Healthcare, a data transfer platform. In addition, the company offers The NOCISCAN Post-Processor Suite comprising NOCICALC, a Class I medical device that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra, and performs various degenerative pain biomarker calculations from those spectra, for each disc examined; and NOCIGRAM, which further processes the NOCICALC results into individual NOCISCORES, on a 0-10 scale, that represent the different relative levels of degenerative pain biomarkers the various discs examined in the patient. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

Selected stocks

Armata Pharmaceuticals, Inc. (ARMP)

Hall Chadwick Acquisition Corp. (HCAC)

Dogwood Therapeutics, Inc. (DWTX)

Tencent Music Entertainment Group (TME)

Boise Cascade, L.L.C. (BCC)